Innocoll Biotherapeutics

Innocoll is committed to improving patient care by confronting some of today’s most important healthcare challenges. Everyone at Innocoll is united by a common goal: to deliver healthcare solutions that make a difference in patients’ lives. We take pride in fostering a culture of collaboration, and we strive to be the best possible partners to the hospitals and doctors we support. Our current late-stage product pipeline, including XARACOLL (bupivacaine HCl) implant and POSIMIR (bupivacaine solution) for infiltration use, are focused on addressing patient needs for postsurgical pain management.